Acutaas Chemicals share news and announcements
NSE: ACUTAASBSE: 543349Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹3,215.30.
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹25,689 Cr347th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 24 Jul 2026
- 66.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 Apr 2026
- 15.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 24 Jul 2026
- 26.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 24 Jul 2026
- 29.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 Apr 2026
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,48,10955.1% delivered
Acutaas Chemicals analyst meets
95 filed, newest first. Page 1 of 2.
Oct 2026
22 Oct · Analysts
Sep 2026
22 Sep · Analysts
Aug 2026
8 Aug · Analysts
Jul 2026
May 2026
14 May · Analysts
Apr 2026
27 Apr · Analysts
Mar 2026
2 Mar · Analysts
Feb 2026
17 Feb · Analysts
Jan 2026
30 Jan · Analysts
22 Jan · Analysts
Nov 2025
11 Nov · Analysts
Oct 2025
10 Oct · Analysts
Aug 2025
20 Aug · Analysts
1 Aug · Analysts
Jul 2025
25 Jul · Analysts
Jun 2025
4 Jun · Analysts
May 2025
23 May · Analysts
Apr 2025
28 Apr · Analysts
24 Apr · Analysts
Mar 2025
6 Mar · Analysts
Feb 2025
22 Feb · Analysts
18 Feb · Analysts
4 Feb · Analysts
Jan 2025
24 Jan · Analysts
Nov 2024
12 Nov · Analysts
12 Nov · Analysts
6 Nov · Analysts
Oct 2024
23 Oct · Analysts
Sep 2024
2 Sep · Analysts
Aug 2024
26 Aug · Analysts
8 Aug · Analysts
3 Aug · Analysts
May 2024
7 May · Analysts
Feb 2024
29 Feb · Analysts
23 Feb · Analysts
10 Feb · Analysts
Nov 2023
29 Nov · Analysts
Aug 2023
16 Aug · Analysts
7 Aug · Analysts
Jun 2023
30 Jun · Analysts
22 Jun · Analysts
22 Jun · Analysts
21 Jun · Analysts
20 Jun · Analysts
15 Jun · Analysts
14 Jun · Analysts
9 Jun · Analysts
8 Jun · Analysts
3 Jun · Analysts